Drug factory · FDA FEI 1000435915

ORIL Industrie

13 rue Auguste Desgenetais, Bolbec, France

France: 1

Problems found, fixed voluntarily at FDA's last inspection, Apr 6, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2010: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
PerindoprilatMakes the active ingredient Xoma (us) LLC 76234-000, 76234-001, 76234-002

FDA inspection history

EndedResultProgramProblems noted
Apr 6, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 14, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 17, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 9, 2010No problems foundDrug Quality Assurance—

Registered with FDA for: api manufacture.